| Product Code: ETC7539410 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Castration-Resistant Prostate Cancer Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Castration-Resistant Prostate Cancer Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India Castration-Resistant Prostate Cancer Therapeutics Market - Industry Life Cycle |
3.4 India Castration-Resistant Prostate Cancer Therapeutics Market - Porter's Five Forces |
3.5 India Castration-Resistant Prostate Cancer Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Castration-Resistant Prostate Cancer Therapeutics Market Revenues & Volume Share, By Drug Delivery Method, 2021 & 2031F |
4 India Castration-Resistant Prostate Cancer Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of castration-resistant prostate cancer in India |
4.2.2 Advancements in medical research leading to the development of innovative therapies |
4.2.3 Growing awareness about prostate cancer and available treatment options |
4.3 Market Restraints |
4.3.1 High cost associated with castration-resistant prostate cancer therapeutics |
4.3.2 Limited access to specialized healthcare facilities in certain regions of India |
4.3.3 Stringent regulatory requirements for approval of new therapies |
5 India Castration-Resistant Prostate Cancer Therapeutics Market Trends |
6 India Castration-Resistant Prostate Cancer Therapeutics Market, By Types |
6.1 India Castration-Resistant Prostate Cancer Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Castration-Resistant Prostate Cancer Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Castration-Resistant Prostate Cancer Therapeutics Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 India Castration-Resistant Prostate Cancer Therapeutics Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F |
6.1.5 India Castration-Resistant Prostate Cancer Therapeutics Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.1.6 India Castration-Resistant Prostate Cancer Therapeutics Market Revenues & Volume, By Radiotherapy, 2021- 2031F |
6.2 India Castration-Resistant Prostate Cancer Therapeutics Market, By Drug Delivery Method |
6.2.1 Overview and Analysis |
6.2.2 India Castration-Resistant Prostate Cancer Therapeutics Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.2.3 India Castration-Resistant Prostate Cancer Therapeutics Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.4 India Castration-Resistant Prostate Cancer Therapeutics Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
7 India Castration-Resistant Prostate Cancer Therapeutics Market Import-Export Trade Statistics |
7.1 India Castration-Resistant Prostate Cancer Therapeutics Market Export to Major Countries |
7.2 India Castration-Resistant Prostate Cancer Therapeutics Market Imports from Major Countries |
8 India Castration-Resistant Prostate Cancer Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials conducted for castration-resistant prostate cancer therapeutics in India |
8.2 Patient enrollment rates in clinical trials for new therapies |
8.3 Adoption rate of novel treatment options for castration-resistant prostate cancer |
9 India Castration-Resistant Prostate Cancer Therapeutics Market - Opportunity Assessment |
9.1 India Castration-Resistant Prostate Cancer Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Castration-Resistant Prostate Cancer Therapeutics Market Opportunity Assessment, By Drug Delivery Method, 2021 & 2031F |
10 India Castration-Resistant Prostate Cancer Therapeutics Market - Competitive Landscape |
10.1 India Castration-Resistant Prostate Cancer Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India Castration-Resistant Prostate Cancer Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here